Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Clinical trial NCT05396118 · UNKNOWN

Trial details

NCT number: NCT05396118
Sponsor: Rigshospitalet, Denmark
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Neuroendocrine Tumors Neuroendocrine Carcinoma Neuroendocrine Carcinoma Metastatic Lymphoma Sarcoma

Start date: 2022-05-18
Primary completion: 2024-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.